"Oral semaglutide: pharmacokinetics, clinical efficacy, and practical considerations." Reviews in Endocrine and Metabolic Disorders
Glucagon-like peptide-1 (GLP-1) is a hormone produced by the small intestine, which is responsible for triggering the pancreas to release insulin, blocking the secretion of another hormone called glucagon, slowing digestion, and making you feel full after eating
Medical Science Monitor 17 , HY5HY9 (2011)
The blend trades that flexibility for the convenience of a single injection at a documented, pre-set ratio
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes: A Population-Based Cohort Study
Cell 166 , 12951307 (2016)